A method of treating patients to inhibit inflammation is disclosed. In the method, an effective amount of calmodulin, a calmodulin analogue or calmodulin receptor agonist is administered to a patient to inhibit production of tumor necrosis factor and/or augment elastase. In another method, an effective amount of calmodulin antagonist is administered to a patient to stimulate immune response or inhibit elastase release. In another embodiment, a diagnostic test is disclosed to be used on patient blood samples to determine individual propensity to regulate tumor necrosis factor and/or elastase by calmodulin, its analogues or receptor agonists.

Oklahoma Medical Research Foundation

Method for regulating inflammation and tumor growth with calmodulin, calmodulin analogues or calmodulin antagonists

The present invention relates to methods and compositions for monitoring, diagnosis, prognosis, and determination of treatment regimens in subjects suffering from or suspected of having a renal injury. In particular, the invention relates to using a one or more assays configured to detect a kidney injury marker selected from the group consisting of Heat shock 70 kDa protein 1, Alpha-1-antitrypsin Neutrophil elastase complex, Stromelysin-1:Metalloproteinase inhibitor 2 complex, 72 kDa type IV collagenase:Metalloproteinase inhibitor 2 complex, Insulin-like growth factor 1 receptor, Myeloid differentiation primary response protein MyD88, Neuronal cell adhesion molecule, and Tumor necrosis factor ligand superfamily member 10 as diagnostic and prognostic biomarkers in renal injuries.

Anderberg; Joseph

Gray; Jeff

McPherson; Paul

Nakamura; Kevin

Kampf; James Patrick

ASTUTE MEDICAL, INC.

Methods and compositions for diagnosis and prognosis of renal injury and renal failure

An apoptosis-associated protease having a relative mass of 24 kilodaltons and a defined amino acid composition is disclosed, together with a method for its purification from a cytoplasmic extract of mammalian cells treated with an apoptosis-inducing agent, such as tumor necrosis factor-.alpha. or UV irradiation, that comprises affinity chromatography with the serine protease inhibitor DK120 followed by heparin-sepharose chromatography. The protease has activity against the elastase-like substrate MAAPV and is capable of inducing apoptosis in isolated U937 cell target nuclei.

Panorama Research, Inc.

24 kilodalton cytoplasmic protease activating DNA fragmentation in apoptosis

elastase

necrosis

elastase/necrosis

Method for regulating inflammation and tumor growth with calmodulin, calmodulin analogues or calmodulin antagonists

Methods and compositions for diagnosis and prognosis of renal injury and renal failure

24 kilodalton cytoplasmic protease activating DNA fragmentation in apoptosis

Vispilnīgākā ārstniecības augu datu bāze, kuru atbalsta zinātne